No Detail Found!

Occurrence of thrombocytopenia in non-cirrhotic hepatitis c positive patients.

Author(s)
Muhammad Ayyaz Department of Gastroenterology, Ayub Teaching Hospital,Abbottabad,Pakistan
Syed Muhamamd Hassan Department of Gastroenterology, Ayub Teaching Hospital,Abbottabad,Pakistan
Muzna Hashmi Department of Microbiology, Quaid-i-Azam University,Islamabad,Pakistan
Muhammad Tahir Khan Capital University of Science & Technology,Islamabad,Pakistan
Anwar Sheed Khan Khyber Medical University Peshawar,Peshawar,Pakistan
Shabir Ahmad Institute of Biological Sciences, Sarhad University of Science and Information Technology,Peshawar,Pakistan
Aamir Aziz Institute of Biological Sciences, Sarhad University of Science and Information Technology,Peshawar,Pakistan
Wasim sajjad Key laboratory of petroleum resources, Gansu province/Key laboratory of petroleum resources research, Institute of Geology and Geophysics, CAS,Lanzhou , China
Muhammad Irfan Institute of Biological Sciences, Sarhad University of Science and Information Technology,Peshawar,Pakistan
Abstract
Thrombocytopenia is commonly encountered hematological abnormality, which might be attributed to hepatitis C virus (HCV) in acute and chronic infection. This study aims to determine the prevalence of thrombocytopenia as a clinical manifestation of chronic HCV infection in non-cirrhotic patients having spleen of normal size. A cross sectional study was carried out in Ayub Teaching Hospital, Abbottabad, Khyber Pakhtunkhwa, Pakistan in Gastroenterology and Medical Outpatient Department from January to October 2017. The investigation was carried out on patients between age 20 to 60 years with anti-HCV antibody positive. All patients having liver cirrhosis, or fibrosis and splenomegaly, or having thrombocytopenia from other causes i.e. any drug use or other chronic infections were excluded from the study. A total of 67 patients fulfilling the criteria were selected. Thrombocytopenia was observed in 34.3% of the subjects, among them 17.9% exhibited mild thrombocytopenia (150000/µL to 400000/µL); 11.9% (51000/µL to 100000/µL) exhibited moderate thrombocytopenia while 4.5% (less than 50000/µL) showed severe thrombocytopenia. Thus, the study exhibited the presence of thrombocytopenia in chronic HCV patients without liver cirrhosis and splenomegaly that proves the contribution of HCV to induce thrombocytopenia.
Publication Details
Page(s) 77-81
DOI DOI not available
Published Journal: Abasyn Journal of Life Sciences, Volume: 1, Issue: 2, Year: 2018

Request the full text from PASTIC

Keywords
Cirrhosis, thrombocytopenia
0

Citations

0

Downloads

49

Views